Abstract
Depression is the most common mental disorder, affecting a large population worldwide. Of the psychiatric syndromes which present mood disorders, major depressive disorder (MDD) is one of the most severe due to the long periods of depressed mood, somatic symptoms, cognitive disturbances, clinically significant distress and impairment in everyday functioning. The causes of MDD are complex and associated with environmental and biological aspects. Treatment comprises structured forms of psychotherapy and antidepressant medication but remission rates are low and justify the implementation of an alternative effective treatment. Various authors have associated physical exercise with the treatment of depression and different biological and psychological hypotheses have been proposed. Several clinical trials have been performed and, while some authors report no apparent association, the majority of the published data demonstrates a positive effect of physical exercise on both depressive symptoms and Quality of Life (QoL). In this review, the current status of exercise associated treatment of MDD is addressed, relevant data and models are discussed, and an updated view of the current situation is presented.
Keywords: Major depressive disorder, MDD, depression, physical exercise, physical activity, Omega-3 fatty acids, osteoporosis, seasonal effects, homozygotic, multigenic, angiogenic factor, Brain Derived Neurotrophic Factor (BDNF), Monoamine, Endorphin, Thermogenic
Current Psychopharmacology
Title: Physical Exercise and Major Depressive Disorder - Where Do We Stand?
Volume: 1
Author(s): Jorge Mota Pereira, Jorge Silverio, Serafim Carvalho, Joaquim Ramos and Jose Carlos Ribeiro
Affiliation:
Keywords: Major depressive disorder, MDD, depression, physical exercise, physical activity, Omega-3 fatty acids, osteoporosis, seasonal effects, homozygotic, multigenic, angiogenic factor, Brain Derived Neurotrophic Factor (BDNF), Monoamine, Endorphin, Thermogenic
Abstract: Depression is the most common mental disorder, affecting a large population worldwide. Of the psychiatric syndromes which present mood disorders, major depressive disorder (MDD) is one of the most severe due to the long periods of depressed mood, somatic symptoms, cognitive disturbances, clinically significant distress and impairment in everyday functioning. The causes of MDD are complex and associated with environmental and biological aspects. Treatment comprises structured forms of psychotherapy and antidepressant medication but remission rates are low and justify the implementation of an alternative effective treatment. Various authors have associated physical exercise with the treatment of depression and different biological and psychological hypotheses have been proposed. Several clinical trials have been performed and, while some authors report no apparent association, the majority of the published data demonstrates a positive effect of physical exercise on both depressive symptoms and Quality of Life (QoL). In this review, the current status of exercise associated treatment of MDD is addressed, relevant data and models are discussed, and an updated view of the current situation is presented.
Export Options
About this article
Cite this article as:
Mota Pereira Jorge, Silverio Jorge, Carvalho Serafim, Ramos Joaquim and Carlos Ribeiro Jose, Physical Exercise and Major Depressive Disorder - Where Do We Stand?, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020167
DOI https://dx.doi.org/10.2174/2211556011201020167 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anesthetic Cardioprotection: The Role of Adenosine
Current Pharmaceutical Design The Endothelial-Mesenchymal Transition (EndMT) and Tissue Regeneration
Current Stem Cell Research & Therapy Interstitial Lung Disease Associated with Collagen Vascular Disease
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Mobile Phone Based Biomedical Imaging Technology: A Newly Emerging Area
Recent Patents on Biomedical Engineering (Discontinued) Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)
Current Pharmaceutical Design A New Method for Measuring Total Antioxidant Capacity in Urine Using the Iodine Starch Agar Based on Agar diffusion
Current Analytical Chemistry Review of Progress in Predicting Protein Methylation Sites
Current Organic Chemistry Heart Failure and Diabetes: Perspective of a Dangerous Association
Current Hypertension Reviews Significance of P2X7 Receptor Variants to Human Health and Disease
Recent Patents on DNA & Gene Sequences Targeting Mitochondrial Oxidative Stress Through Lipoic Acid Synthase: A Novel Strategy to Manage Diabetic Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology Vascular effects of flavonoids
Current Medicinal Chemistry Inducers of Heme Oxygenase-1
Current Pharmaceutical Design An Overview of Compounds Derived from the Shikimate and Phenylpropanoid Pathways and Their Medicinal Importance
Mini-Reviews in Medicinal Chemistry Emerging Targets for the Treatment of Dyslipidemia
Current Medicinal Chemistry Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones
Anti-Cancer Agents in Medicinal Chemistry In Silico hERG Modeling: Challenges and Progress
Current Computer-Aided Drug Design Variations and Abnormalities of Major Thoracic Vascular Structures
Current Medical Imaging Fragmented ECG as a Risk Marker in Cardiovascular Diseases
Current Cardiology Reviews Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets